Hepatitis C News and Research

Latest Hepatitis C News and Research

EHR-based prompt in primary care increases HCV screening rates among baby boomers

In a recent study, screening rates for hepatitis C virus (HCV) infection among baby boomers increased fivefold in the year following implementation of an electronic health record (EHR)-based prompt for primary care physicians.

14 Sep 2017

Intense sanitization effort as Hepatitis A outbreak in San Diego claims 16 lives

An outbreak of hepatitis A in San Diego is being investigated by the Public Health Services Division, in the County of San Diego Health and Human Services Agency. Most of the people affected with hepatitis A are the illicit drug users and homeless individuals. The spread from one person to another through fecal contamination.

14 Sep 2017

Researchers discover major mechanism in development of liver cancer

Liver cancer is the second-leading cause of cancer-related death and represents the fastest rising cancer worldwide. In most cases, the tumor develops in patients with chronic liver disease.

11 Sep 2017

Meningitis B vaccine’s high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

8 Sep 2017

Direct-acting antiviral therapy found to be safe, effective in patients with CKD and HCV infection

A new study indicates that direct-acting antiviral therapy is safe and effective in patients with chronic kidney disease (CKD) and Hepatitis C virus (HCV) infection.

8 Sep 2017

Hepatitis A outbreak among population of San Diego

The San Diego population is facing one of the worst outbreaks of infective viral disease Hepatitis A. the outbreak began last November and is still going strong with no signs of reduction in the infection rates. The homeless are one of the worst hit.

3 Sep 2017

Vaccination efforts in poor countries prevent 20 million deaths, provide economic benefits

Vaccination efforts made in the world's poorest countries since 2001 will have prevented 20 million deaths and saved $350 billion in health-care costs by 2020, according to a new study from the University of North Carolina at Chapel Hill.

1 Sep 2017

Pioneering cancer gene therapy gets green light — and $475,000 price tag

The country's first approved gene therapy — approved Wednesday to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment, its manufacturer announced.

30 Aug 2017

New app could lead to earlier detection of pancreatic cancer by snapping a smartphone selfie

Pancreatic cancer has one of the worst prognoses -; with a five-year survival rate of 9 percent -; in part because there are no telltale symptoms or non-invasive screening tools to catch a tumor before it spreads.

29 Aug 2017

LSU Health New Orleans receives $10 million grant to support research on virus-induced cancers

The National Institute of General Medical Sciences has awarded LSU Health New Orleans a $10 million grant over five years to support new basic research studies advancing the development new diagnostic and therapeutic approaches for virus-induced cancers.

26 Aug 2017

Self-powered, paper-based electrochemical devices detect biomarkers and identify diseases

A new medical-diagnostic device made out of paper detects biomarkers and identifies diseases by performing electrochemical analyses - powered only by the user's touch - and reads out the color-coded test results, making it easy for non-experts to understand.

22 Aug 2017

Pork products associated with carrying hepatitis E virus in Britain

Pork products that are being sold at a leading supermarket has been associated with carrying a deadly hepatitis virus warns the researchers at the Public Health England (PHE).

20 Aug 2017

Children need to be up-to-date on immunizations before heading back-to-school

While we prepare our children to go back to school, parents should check and make sure their children are current on all vaccinations before the start of the school year or they may not be able to start on the first day.

17 Aug 2017

Researchers identify role of blood-filtering organs in fighting against viral infections

New information about how and where the innate immune system fights off viral infections that enter through the skin could lead to better treatments for viruses like Zika, dengue and measles, according to Penn State College of Medicine researchers.

17 Aug 2017

Routinely used hospital tool can predict poor outcomes in liver transplant recipients

A routinely used hospital tool can predict which liver transplant recipients are more likely to do poorly after surgery, according to a study led by Cedars-Sinai.

10 Aug 2017

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

According to a recent announcement made by Public Health England, there is a global shortage of vaccines used against hepatitis B infection. This announcement is followed up by a “prioritisation guidance” which means that persons who are at greatest risk of getting hepatitis B are to be vaccinated on priority if they have not received the vaccine before.

7 Aug 2017

Congress revamps housing program to benefit areas where HIV is spreading

In a bipartisan push, Congress has restructured a federal program that provides housing assistance for people living with HIV to funnel more money into areas struggling to control the outbreak.

7 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

Representatives from the London Assembly and local authorities in the Capital are set to meet with third sector and public health representatives in a roundtable meeting hosted by biopharmaceutical company, AbbVie, on World Hepatitis Day.

3 Aug 2017

Hepatitis C News and Research

Latest Hepatitis C News and Research

EHR-based prompt in primary care increases HCV screening rates among baby boomers

Intense sanitization effort as Hepatitis A outbreak in San Diego claims 16 lives

Researchers discover major mechanism in development of liver cancer

Meningitis B vaccine’s high price tag poses a health care conundrum

Direct-acting antiviral therapy found to be safe, effective in patients with CKD and HCV infection

Hepatitis A outbreak among population of San Diego

Vaccination efforts in poor countries prevent 20 million deaths, provide economic benefits

Pioneering cancer gene therapy gets green light — and $475,000 price tag

New app could lead to earlier detection of pancreatic cancer by snapping a smartphone selfie

LSU Health New Orleans receives $10 million grant to support research on virus-induced cancers

Self-powered, paper-based electrochemical devices detect biomarkers and identify diseases

Pork products associated with carrying hepatitis E virus in Britain

Children need to be up-to-date on immunizations before heading back-to-school

Researchers identify role of blood-filtering organs in fighting against viral infections

Routinely used hospital tool can predict poor outcomes in liver transplant recipients

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

Congress revamps housing program to benefit areas where HIV is spreading

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in